Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brugada Syndrome Substrate Characterization and Ablation: Insights From ECG BrS Type I Pattern, Novel Prognostic Index dST-Tiso and High Density Mapping

NCT05643209 is registered in ClinicalTrials.gov with Maria Cecilia Hospital as lead sponsor.

NCT NCT05643209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05643209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brugada Syndrome Substrate Characterization and Ablation: Insights From ECG BrS Type I Pattern, Novel Prognostic Index dST-Tiso and High Density Mapping
Lead sponsor
Maria Cecilia Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2023
Completion date
June 30, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brugada syndrome